Central Vascular Access Devices Market contains market size and forecasts of Central Vascular Access Devices in global, including the following market information:
- Global Central Vascular Access Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Central Vascular Access Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Central Vascular Access Devices companies in 2021 (%)
The global Central Vascular Access Devices market was valued at 2153.6 million in 2021 and is projected to reach US$ 3300.2 million by 2028, at a CAGR of 6.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Peripherally Inserted Central Catheters (PICC) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Central Vascular Access Devices include Becton, Dickinson and Company (U.S.), C. R. Bard, Inc. (U.S.), Smiths Medical, Inc. (U.K.), Teleflex Incorporated (U.S.), B.Braun Melsungen AG (Germany), NIPRO Medical Corporation (Japan), Edwards Lifesciences Corporation (U.S.), Terumo Corporation (Japan) and Vygon Ltd. (U.K.), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Central Vascular Access Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Central Vascular Access Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Central Vascular Access Devices Market Segment Percentages, by Type, 2021 (%)
- Peripherally Inserted Central Catheters (PICC)
- Tunneled Catheters
- Non Tunneled Catheters
- Implanted Ports
Global Central Vascular Access Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Central Vascular Access Devices Market Segment Percentages, by Application, 2021 (%)
- Drug Administration
- Fluid And Nutrition Administration
- Blood Transfusion
- Diagnostics & Testing
Global Central Vascular Access Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Central Vascular Access Devices Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Central Vascular Access Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Central Vascular Access Devices revenues share in global market, 2021 (%)
- Key companies Central Vascular Access Devices sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Central Vascular Access Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Becton, Dickinson and Company (U.S.)
- C. R. Bard, Inc. (U.S.)
- Smiths Medical, Inc. (U.K.)
- Teleflex Incorporated (U.S.)
- B.Braun Melsungen AG (Germany)
- NIPRO Medical Corporation (Japan)
- Edwards Lifesciences Corporation (U.S.)
- Terumo Corporation (Japan)
- Vygon Ltd. (U.K.)
- Ameco Medical (Egypt)
- AngioDynamics (U.S.)
- Romsons Scientific & Surgical Pvt. Ltd. (India)
- PRODIMED (France)
Industry Market Size
